<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "capecitabine tab">
<dose><value>1250</value>
<value>1000</value>
<value>500</value>
<value>650</value>
<value>800</value>
<value>950</value>
<value>1150</value>
<value>1300</value>
<value>1450</value>
<value>1500</value>
<value>1650</value>
<value>1800</value>
<value>1950</value>
<value>2000</value>
<value>2150</value>
<value>2300</value>
<value>2450</value>
<value>2500</value>
<value>2650</value>
<value>2800</value>
<value>2950</value>
<value>3000</value>
<value>3150</value>
</dose>
<route><value>PO</value>
</route>
<strength><value>150 mg</value>
<value>500 mg</value>
</strength>
<frequency><value>BID</value>
</frequency>
<instruction><value>Administer in the morning and evening.</value>
<value>Start treatment during the evening of Day 1 and last dose during morning of Day 15. Administer in the morning and evening.</value>
</instruction>
<volume></volume>
<units><value>mg/m2</value>
<value>mg</value>
</units>
<Population><value>ADULT</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Monotherapy. Treatment cycle of 14 days of treatment followed by 7 day rest period. If ANC is greater than or equal to 1.5 X 109/L AND Platelets are greater than or equal to 75 X 109/L: Give as ordered. If ANC is less than 1.5 X109/L OR Platelets are less than 75 X 109/L: Delay 1 week. Dosage adjust for renal impairment (Cycle #1 ONLY): If CrCl is greater than 50 mL/minute: NO dosage adjustment. If CrCl is 30 to 50 mL/minute: Reduce dose to 75%. If CrCl is less than 30 mL/minute: DO NOT TREAT. Recommend rounding dose to a &amp;quot;dispensable&amp;quot; dose amount.</value>
<value>Combination therapy. Treatment cycle of 14 days of treatment followed by 7 day rest period. If ANC is greater than or equal to 1.5 X 109/L AND Platelets are greater than or equal to 75 X 109/L: Give as ordered. If ANC is less than 1.5 X109/L OR Platelets are less than 75 X 109/L: Delay 1 week. Dosage adjust for renal impairment (Cycle #1 ONLY): If CrCl is greater than 50 mL/minute: NO dosage adjustment. If CrCl is 30 to 50 mL/minute: Reduce dose to 75%. If CrCl is less than 30 mL/minute: DO NOT TREAT. Recommend rounding dose to a &amp;quot;dispensable&amp;quot; dose amount.</value>
<value>Monotherapy. Treatment cycle of 14 days of treatment followed by 7 day rest period.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3351</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3352</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus></AHSFormularyStatus>
<HighAlert><value>HIGH ALERT MEDICATION</value>
</HighAlert>
</drug>